These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 9132917

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, Mazzarella G, Raia V.
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [Abstract] [Full Text] [Related]

  • 4. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 5. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Dec; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 6. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract] [Full Text] [Related]

  • 7. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
    Bush A.
    Pediatr Pulmonol; 1998 Feb; 25(2):79-82. PubMed ID: 9516089
    [No Abstract] [Full Text] [Related]

  • 8. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.
    Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
    [Abstract] [Full Text] [Related]

  • 9. Dornase alfa improves the health-related quality of life among Brazilian patients with cystic fibrosis--a one-year prospective study.
    Rozov T, de Oliveira VZ, Santana MA, Adde FV, Mendes RH, Paschoal IA, Caldeira Reis FJ, Higa LY, Toledo AC, Pahl M, Pulmozyme Study Group.
    Pediatr Pulmonol; 2010 Sep; 45(9):874-82. PubMed ID: 20583292
    [Abstract] [Full Text] [Related]

  • 10. Pulmozyme--Dornase alfa.
    Gutteridge C, Kuhn RJ.
    Pediatr Nurs; 1994 Sep; 20(3):278-9. PubMed ID: 8008477
    [Abstract] [Full Text] [Related]

  • 11. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
    Bakker EM, Volpi S, Salonini E, Müllinger B, Kroneberg P, Bakker M, Hop WC, Assael BM, Tiddens HA.
    Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
    [Abstract] [Full Text] [Related]

  • 12. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
    McCoy K, Hamilton S, Johnson C.
    Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
    [Abstract] [Full Text] [Related]

  • 13. The role of dornase alfa in the treatment of cystic fibrosis.
    Cramer GW, Bosso JA.
    Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
    [Abstract] [Full Text] [Related]

  • 14. Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.
    MacConnachie AM.
    Intensive Crit Care Nurs; 1998 Apr; 14(2):101-2. PubMed ID: 9814214
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME.
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [Abstract] [Full Text] [Related]

  • 16. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
    Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.
    Respiration; 2001 Mar; 68(2):160-4. PubMed ID: 11287830
    [Abstract] [Full Text] [Related]

  • 17. The use of recombinant human dornase alfa in CF.
    Cox C.
    Paediatr Nurs; 1995 Nov; 7(9):29-31. PubMed ID: 8705343
    [No Abstract] [Full Text] [Related]

  • 18. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 19. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA, Hilton J, Jepson B, Smith L.
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [Abstract] [Full Text] [Related]

  • 20. Dornase alfa therapy in cystic fibrosis: who should get it?
    Kanga JF.
    Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.